A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Human natural killer (NK) cells express several killer cell immunoglobulin (Ig)-like receptors (KIRs) that inhibit their cytotoxicity upon recognition of human histocompatibility leukocyte antigen (HLA) class I molecules on target cells. Additional members of the KIR family, including some that deliver activation signals, have unknown ligand specificity and function. One such KIR, denoted KIR2DL4, is structurally divergent from other KIRs in the configuration of its two extracellular Ig domains and of its transmembrane and cytoplasmic domains. Here we show that recombinant soluble KIR2DL4 binds to cells expressing HLA-G but not to cells expressing other HLA class I molecules. Unlike other HLA class I-specific KIRs, which are clonally distributed on NK cells, KIR2DL4 is expressed at the surface of all NK cells. Furthermore, functional transfer of KIR2DL4 into the cell line NK-92 resulted in inhibition of lysis of target cells that express HLA-G, but not target cells that express other class I molecules including HLA-E. Therefore, given that HLA-G expression is restricted to fetal trophoblast cells, KIR2DL4 may provide important signals to maternal NK decidual cells that interact with trophoblast cells at the maternal-fetal interface during pregnancy.
Rajagopalan
S
S
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA.
Long
E O
EO
D002462:Cell Membrane / Q000737:chemistry; D003602:Cytotoxicity, Immunologic; D005260:Female; D005333:Fetus / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007106:Immune Sera; D007141:Immunoglobulin Fc Fragments / Q000235:genetics; D007694:Killer Cells, Natural / Q000276:immunology*; D011247:Pregnancy; D011485:Protein Binding; D011971:Receptors, Immunologic / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D054340:Receptors, KIR; D054345:Receptors, KIR2DL4; D054346:Receptors, KIR2DL5; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction; D012995:Solubility; D014158:Transcription, Genetic; D014162:Transfection; D014327:Trophoblasts / Q000276:immunology*
D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D007106:Immune Sera; D007141:Immunoglobulin Fc Fragments; C515079:KIR2DL4 protein, human; D011971:Receptors, Immunologic; D054340:Receptors, KIR; D054345:Receptors, KIR2DL4; D054346:Receptors, KIR2DL5; D011993:Recombinant Fusion Proteins